BPI-9016M is an Orally Active and Selective Dual c-Met/AXL Inhibitor
c-Met is a membrane-spanning receptor tyrosine kinase. It has a high affinity for binding to hepatocyte growth factor (HGF). As we all know, HGF/c-Met signaling often involves activation of its downstream…